Advertisement

We need your help now

Support from readers like you keeps The Journal open.

You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.

If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.

Chris Ison/PA Archive/Press Association Images
Recall

Batches of three cancer drugs recalled by Medicines Board

The Irish Medicines Board said it was a purely precautionary measure.

THE IRISH MEDICINES Board (IMB) has recalled batches of three cancer treatment drugs that were sent to hospitals last week.

The IMB says the measure is purely precautionary because of a “theoretical risk of contamination” and that patients should not be alarmed.

“No batch of any of the concerned medicines has been found to be defective in any way,” a statement said.

The drugs that have been recalled are Busilvex and Velcade 3.5mg which are used to treat bone marrow cancer. The recall follows advice from the European Medicines Agency. Replacement medications are being made available for these two treatments.

The drug Caelyx, a treatment for ovarian and other cancers, is not being prescribed to any new patients but the IMB said that patients who are already receiving treatment should continue with it.

Your Voice
Readers Comments
3
    Submit a report
    Please help us understand how this comment violates our community guidelines.
    Thank you for the feedback
    Your feedback has been sent to our team for review.